TECENTRIQ is a programmed death-ligand 1 (PD-L1) blocking antibody indicated:Urothelial Carcinoma, Non-Small Cell Lung Cancer (NSCLC), Triple-Negative Breast Cancer (TNBC), Small Cell Lung Cancer (SCLC), Metastatic Treatment of TNBC, Small Cell Lung Cancer.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of TECENTRIQ (atezolizumab) injectionn brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the TECENTRIQ (atezolizumab) injectionn medicine cost price in India.
The order for TECENTRIQ (atezolizumab) injectionn will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Atezolizumab is used to treat certain types of breast cancer, or bladder and urinary tract cancer. Atezolizumab is also used to treat non-small cell lung cancer. Atezolizumab is used when the cancer has spread to other parts of the body (metastatic), or cannot be removed by surgery.
DARZALEX (atezolizumab) injection, for intravenous use. Initial U.S. Approval – 2015
Generic Name: atezolizumab
Injection: 840 mg/14 mL (60 mg/mL) and 1200 mg/20 mL (60 mg/mL) solution in a single-dose vial
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand TECENTRIQ (atezolizumab) injectionn on prescription and Import License in Patient's Name only.
For overseas patients, TECENTRIQ (atezolizumab) injectionn can be made available in Send your enquiry to find TECENTRIQ (atezolizumab) injectionn in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For TECENTRIQ (atezolizumab) injectionn Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
A Look Back at FDA News from December 2019 For More Details
Tecentriq + Chemo Approved for First-Line NSCLC Without EGFR/ALK Mutations For More Details